Share this:
      Issue 28  •  December 2024                                                                 PMI Grants Team

Funding Opportunities by Agency

Discovery Boost Grants (DBG) high-risk, high-reward exploratory cancer research.  Awards are for up to 2 years with $135,000 a year for direct costs, plus 10% allowable indirect costs.  Due: 04/01/25
Mission Boost Grants (MBG)  Stage I Mission Boost: $135,000/year for two years direct costs, plus 10% indirect costs.  Stage II Mission Boost:  Applicants may propose up to 18 months and $545,000 for direct costs, plus 10% indirect costs. Due: 04/01/25
Research Scholar Grants  Awards are for up to 4 years with up to $215,000/year for direct costs, plus 10% allowable indirect costs. Due: 04/01/25
Postdoctoral Fellowship  $66,000 Yr 1, $68,000 Yr 2,  $70,0000 Yr 3, and additional $4,000/year Fellowship allowance. Due: 04/01/25
Clinician Scientist Development Grant (CSDG)  Awards may be for 3 to 5 years with $135,000 a year for direct costs, plus 8% allowable indirect costs. Due: 04/01/25
2025 Implementation Science Award $133,333/year for three years including 10% indirects. Full application: 02/05/25
AHA 2025 Tranformational Project Award $100,000/year for three years, including 10% indirects. Full application: 02/13/25
Damon Runyon Fellowship Award  Stipend: $70,000 Yr 1, $72,000 Yr 2, $74,000, Yr 3, and $76,000 Yr 4 plus 2K/year expense allowance. The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee.  Applications due by 03/17/25        
Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award Stipend: $70,000 Yr 1, $72,000 Yr 2, $74,000, Yr 3, and $76,000, Yr 4 plus 2K/year expense allowance.  The Damon Runyon will retire up to $100,000 of any qualifying medical school debt still owed by the Fellow. Applications due: 08/15/25                              
PAR-24-265 Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed).  Minimum award $50,000; maximum award $750,000.  Due 06/02/25
PAR-24-264 High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed).  Minimum award $750,001; maximum award $2,000,000.  Due 06/02/25                   
NOT-OD-23-032 Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards Up to 70K.  Deadlines vary by awarding IC.
PAR-23-275 NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)  Application budgets are not limited but need to reflect the actual needs of the proposed project.  Next AIDS deadline: 01/07/25, Standard due date: 02/05/25
PAR-24-075 Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) Application budgets are not limited but need to reflect the actual needs of the proposed project.  Next due date:01/28/25
PAR-23-145 Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)   up to $250,000 direct costs/year.  Due: 02/03/25
PA-24-194 NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Not Allowed)  Salary and research costs may be requested to the level provided by the awarding Institute or Center plus indirects.  Due: 02/12/25
PAR-24-225 Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)  Salary and research costs may be requested to the level provided by the awarding Institute or Center plus indirects. Due: 02/12/25
PAR-24-037 HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)   Up to $2,500,000 directs/year. LOI: 30 days prior to application deadline.  Due: 03/13/25
PAR-23-024 Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional)  Direct costs are limited to $350,000 per year.  Due: 05/01/25
NIH Standard Deadlines
January
AIDS AND AIDS-Related Applications (New, 
Renewal, Resubmission, Revision) Routing: 12/27/24, Sponsor: 01/07/25
P Series (New, Renewal, Resubmission, Revision) Routing: 01/14/25, Sponsor: 01/25/25 
 
R18U18R25 (New, Renewal, Resubmission, Revision) Routing: 01/14/25, Sponsor: 01/25/25

T & D Series (New, Renewal, Resubmission, Revision)  Routing: 01/14/25, Sponsor: 01/25/25
C06/UC6
(New, Renewal, Resubmission, Revision) Routing: 01/14/25, Sponsor: 01/25/25
February
R01 (New)  Routing: 01/24/25, Sponsor: 02/05/25
U01 (New) Routing: 01/24/25, Sponsor: 02/05/25
K Series (New) Routing: 01/31/25, Sponsor: 02/12/25 
R21 (New) Routing: 02/04/25, Sponsor: 02/16/25 
March  
R01 (Renewal, Resubmission, Revision) Routing: 02/21/25, Sponsor: 03/05/25
U01 (Renewal, Resubmission, Revision) Routing: 02/21/25, Sponsor: 03/05/25
K Series (New) Routing: 02/28/25, Sponsor: 03/12/25
R21 (New) Routing: 03/04/25, Sponsor: 03/16/25
April
F series (New, Renewal, Resubmission)  Routing: 03/27/25, Sponsor: 04/08/25
R13U13 (New, Renewal, Resubmission, Revision) Routing: 04/01/25, Sponsor: 04/12/25 
May
AIDS AND AIDS-Related Applications. (New, 
Renewal, Resubmission, Revision) Routing: 04/25/25, Sponsor: 05/07/25
P Series (New, Renewal, Resubmission, Revision) Routing: 05/14/25, Sponsor: 05/25/25 
 
R18U18R25 (New, Renewal, Resubmission, Revision) Routing: 05/14/25, Sponsor: 05/25/25

T & D Series (New, Renewal, Resubmission, Revision)  Routing: 05/14/25, Sponsor: 05/25/25
C06/UC6
(New, Renewal, Resubmission, Revision) Routing: 05/14/25, Sponsor: 05/25/25

Additional Funding Opportunities:
2025 LUPUS Insight Prize $100,000. Request for Nominiations due: 12/20/24
Jane Coffin Childs Memorial Fund for Medical Research 3 year fellowship: 70K - Yr 1, 72K - Yr 2, and 74K - Yr 3 plus 2K/year research allowance.  Proposals due: 01/31/25
VUMC Faculty Research Scholars $110,000/year, SOI: 01/16/25, full application 02/15/25
Retirement of NIH’s Automated Just-in-Time Email Notification 
The automated Just-In-Time email, generated by the eRA system and sent to applicants for all applications that receive an overall impact score of 30 or less, is retired effective October 1, 2024.
Official notification of the need for JIT material(s) will continue to be sent directly by NIH staff from the awarding Institute/Center to those who are required to provide the material(s). View
Additional information is available via the following links:
Missing PMCIDs and other common errors on proposals 
The PMI grants team encourages applicants to review these items often overlooked for compliance on NIH proposals. View...

Planning a proposal submission in the next 2 - 3 months?

In an effort to better serve you, the PMI grants team requests that PIs and Fellows notify us as far in advance as possible of submission plans.  This ensures ample time to complete departmental requirements and also route to OSP for review by their deadline.  Here is the link to the new SRS intake tool for new/resubmission requests: View...

Have a pressing inquiry regarding submissions or post-award items? 

We're here to help! Candice Stevens, Associate Director, Lauren Milam, Sr Financial Manager, Edith Ashcraft, Sr Financial Analyst, Doug Smith, Sr Financial Analyst, Leigh Thompson, Budget Accounting Analyst Post-Award, Karin Sack, Sr Grants Manager,  and Alethea Kelly, Grants Manager.
Vanderbilt University Medical Center 1161 21st Ave S | Nashville, TN 37232 US
powered by emma
Subscribe to our email list.